- Home
- WLDS vs SLRX Comparison
WLDS vs SLRX Comparison
Compare WLDS & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDS
- SLRX
- Stock Information
- Founded
- WLDS 2014
- SLRX N/A
- Country
- WLDS Israel
- SLRX United States
- Employees
- WLDS N/A
- SLRX N/A
- Industry
- WLDS Computer Communications Equipment
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- WLDS Telecommunications
- SLRX Health Care
- Exchange
- WLDS Nasdaq
- SLRX Nasdaq
- Market Cap
- WLDS 2.0M
- SLRX 1.8M
- IPO Year
- WLDS 2022
- SLRX N/A
- Fundamental
- Price
- WLDS $1.62
- SLRX $0.72
- Analyst Decision
- WLDS
- SLRX
- Analyst Count
- WLDS 0
- SLRX 0
- Target Price
- WLDS N/A
- SLRX N/A
- AVG Volume (30 Days)
- WLDS 988.6K
- SLRX 23.3K
- Earning Date
- WLDS 12-24-2024
- SLRX 05-14-2025
- Dividend Yield
- WLDS N/A
- SLRX N/A
- EPS Growth
- WLDS N/A
- SLRX N/A
- EPS
- WLDS N/A
- SLRX N/A
- Revenue
- WLDS $522,000.00
- SLRX N/A
- Revenue This Year
- WLDS N/A
- SLRX N/A
- Revenue Next Year
- WLDS N/A
- SLRX N/A
- P/E Ratio
- WLDS N/A
- SLRX N/A
- Revenue Growth
- WLDS 536.59
- SLRX N/A
- 52 Week Low
- WLDS $1.20
- SLRX $0.45
- 52 Week High
- WLDS $54.40
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- WLDS 47.28
- SLRX 41.78
- Support Level
- WLDS $1.60
- SLRX $0.68
- Resistance Level
- WLDS $1.74
- SLRX $0.80
- Average True Range (ATR)
- WLDS 0.15
- SLRX 0.04
- MACD
- WLDS 0.02
- SLRX -0.01
- Stochastic Oscillator
- WLDS 31.11
- SLRX 8.93
About WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.